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Abstract
Background: DNA microarray technology has had a great impact on muscle research and microarray gene
expression data has been widely used to identify gene signatures characteristic of the studied conditions. With the
rapid accumulation of muscle microarray data, it is of great interest to understand how to compare and combine
data across multiple studies. Meta-analysis of transcriptome data is a valuable method to achieve it. It enables to
highlight conserved gene signatures between multiple independent studies. However, using it is made difficult by
the diversity of the available data: different microarray platforms, different gene nomenclature, different species
studied, etc.
Description: We have developed a system tool dedicated to muscle transcriptome data. This system comprises a
collection of microarray data as well as a query tool. This latter allows the user to extract similar clusters of co-
expressed genes from the database, using an input gene list. Common and relevant gene signatures can thus be
searched more easily. The dedicated database consists in a large compendium of public data (more than 500 data
sets) related to muscle (skeletal and heart). These studies included seven different animal species from
invertebrates (Drosophila melanogaster, Caenorhabditis elegans) and vertebrates (Homo sapiens, Mus musculus, Rattus
norvegicus, Canis familiaris, Gallus gallus). After a renormalization step, clusters of co-expressed genes were
identified in each dataset. The lists of co-expressed genes were annotated using a unified re-annotation procedure.
These gene lists were compared to find significant overlaps between studies.
Conclusions: Applied to this large compendium of data sets, meta-analyses demonstrated that conserved patterns
between species could be identified. Focusing on a specific pathology (Duchenne Muscular Dystrophy) we
validated results across independent studies and revealed robust biomarkers and new pathways of interest. The
meta-analyses performed with MADMuscle show the usefulness of this approach. Our method can be applied to
all public transcriptome data.
Background
Our understanding of muscle physiology has evolved
through the years by extensive studies aimed at identify-
ing molecular and physiological mechanisms involved in
normal muscle function and disease. The emergence of
microarrays in the early 1990 s paved the way for the
expansion of this area of research. This technology
reliably quantifies the expression levels of the tran-
scripts, providing a snapshot of the activity of several
tens of thousands of mRNAs simultaneously [1-3]. Gene
expression analysis enables to identify biomarkers [4,5]
and gene signatures [6,7] in human and animal models.
Gene expression studies in the field of muscle
research have generally been carried out using a rather
limited set of conditions and replicates. Therefore,
experimental designs tend to focus on a few specific
research questions [see e.g. [8]]. Microarrays have
allowed the exploration of many fields on a genomic
* Correspondence: daniel.baron@nantes.inserm.fr
1INSERM, U915, Nantes, F-44000 France
Full list of author information is available at the end of the article
Baron et al. BMC Genomics 2011, 12:113
http://www.biomedcentral.com/1471-2164/12/113
© 2011 Baron et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
scale. For instance, the molecular diversity of muscle
fiber types, the physiological plasticity and adaptation of
muscle, as well as muscle atrophy, muscle disease and
muscle pharmacogenomics [9-11].
In consequence, microarray data has accumulated
rapidly. The transcriptome data can be found in dedi-
cated [e.g. Public Expression Profiling Resource PEPR
[12]] or generic databases [e.g. Gene Expression Omni-
bus GEO [13]]. Collecting the different microarray data
sets for meta-analysis adds a new dimension to gene
expression data analysis by combining a large set of
experimental conditions [14]. The quality of any meta-
analysis depends on the quality of the underlying data
[15]. While considerable divergence across different
microarray platforms has been observed in the past
[16,17], their current accuracy and reproducibility
[18,19] now enable reliable comparisons to be made
today. Since the landmark study by Rhodes et al. [20],
several recent meta-analysis studies [21-24] have led to
important results particularly in the field of cancer
research [25-28]. For a given pathology or tissue, meta-
analysis yields robust lists of differentially expressed
genes (or DEGs). In such a case, each set of data can be
considered as an independent validation step [29-31]
enhancing the signal-to-noise ratio [20-24]. In addition,
new pathways - that could not have been previously
identified in isolated data sets - can emerge from a
meta-analysis [32,33]. Finally, when applied to different
pathologies, meta-analyses bring to light interesting dif-
ferences or similarities [34].
Performing such comparisons across different organ-
isms appears to be a particularly promising approach
[35-37] to better understanding of human diseases.
Although differences exist [38], a careful meta-analysis
between species can also reveal similarities [39-41]. The
animal model can thus replicate some aspects of the
human disease [42], yielding important insights into the
pathogenic mechanisms [43]. Recently, Calura et al. [44]
identified a common molecular pathway of atrophy in
muscle of multiple species under diverse physiological
conditions. This work demonstrates that such compari-
sons are possible and can be very useful in the field of
muscle research. This was generalized by Jelier et al.
[45] who systematically compared 102 muscle-related
microarray data sets, based on lists of up- and down-
regulated DEGs.
There is a substantial potential for novel discoveries
by comparing (and associating) microarray studies.
Doing so requires, however, a concerted effort to iden-
tify and remove obstacles from the routine mass com-
parison of microarray data. The objective is to make this
amount of data accessible and comparable for the broad
scientific community in the field of muscle research.
Such databasing allows for a systematic comparison of
the results from different studies in order to identify
consistent expression patterns [46]. Notably, experimen-
tal researchers can interpret new data by exploring these
biologically significant patterns. Based on this concept,
several web tools have already been developed. They can
be divided into two main groups: the first group aims to
compare lists of DEGs, whereas the second analyses
gene co-expression across data sets.
In the first group, two databases have emerged to host
and quickly integrate the results of microarray experi-
ments: LOLA (List Of Lists Annotated) [47] and L2L
(List to List) [48]. LOLA and L2L both gather lists of
published DEGs. They allow investigators to compare
their own data to lists of DEGs from different platforms
and species in order to identify underlying patterns.
However, they are quite limited by the size of the data-
base and the reliance upon the way the lists were cre-
ated (e.g. heterogeneous processing of the studies). To
solve this problem, other tools, based on the re-analysis
of data sets, have been developed with varying degrees
of success [see [49] for review]. A major problem was
the low amount of meaningful raw data deposited in
public databases [50]. A more advanced comparison
strategy of significant gene lists was provided by Onco-
mine [51] and GeneChaser (GENE CHAnge browSER)
[52]. Oncomine is a comprehensive and expertly anno-
tated database of gene expression studies. The collection
comprises 25,447 samples in 360 experiments taken
from 40 cancer types. This tool facilitates the identifica-
tion of DEGs between cancer and normal tissues or
among different cancer subtypes across a large collec-
tion of microarray data. This system was successful in
performing comparative meta-profiling to identify
shared gene expression signatures. However, this feature
does not appear to be accessible to the user. Likewise,
GeneChaser [52] automatically re-annotated and ana-
lyzed 1,515 GEO data sets from 231 microarray types
across 42 species. It performed 12,658 group-versus-
group comparisons to identify biological and clinical
conditions in which a set of genes is differentially
expressed. This tool also provides statistical and graphi-
cal representations to interpret these data. Two variant
strategies have also been developed, both using signed
rank genes as the basis for DEG ‘signatures’ from a
two-group comparison. The first one is a microarray
database search algorithm in an application called the
Connectivity Map (CMAP) [53]. It gathers a reliable but
small number (564) of drug-related cancer signatures in
ten cell lines and derived from one laboratory using a
single microarray platform. However, signatures derived
from other platforms were not demonstrated to work
with CMAP. The second strategy called EXALT
(EXpression signature AnaLysis Tool) [54] holds thou-
sands of DEGs (16,181) extracted from a large formatted
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collection of microarray results from GEO and pub-
lished cancer studies. This collection represents hun-
dreds of different experiments on many different tissues
and generated on multiple platforms. The statistical
approach used by the authors is similar to that proposed
by Rhodes et al. [30]. It performs statistical tests and
then calculates a p-value for each probe, separately for
each study, resulting in a list of statistically de-regulated
genes for each data set. However, these DEG-based
methods have clear caveats. They often use a single sig-
nificance test to extract DEGs from all experimental
designs, and significant genes are defined based on a
two-group comparison strategy. Although they adhere
strictly to the group design specified by the investiga-
tors, DEGs cannot always be extracted from microarray
data sets. Some GEO [13] data sets do not have suffi-
cient information to provide statically reliable results.
Additionally, no signature can be produced if a compari-
son between two groups is not statistically significant.
Finally, additional novel comparisons within a data set
are not possible: the current GEO data structure does
not provide a computable attribute to automatically
identify this type of experiment or hypothesis. To this
end, other comparison methods, based on co-expression
analysis of genes, have been considered. It has been
shown that a sufficiently large and diverse set of profiles
obtained under various physiological conditions results
in the identification of co-regulated transcript groups
[55]. Gene co-expression is conserved across microarray
data sets [22] and can be identified in a compendium of
gene expression data [56]. This strategy yields the detec-
tion of modules of co-expressed genes which are either
specific to one physiological condition or shared across
a set of different physiological conditions [57]. This
approach of cross-platform analysis of microarray data
has allowed the unraveling of networks of transcription
factors in yeast [24]. This work examined the expression
patterns of co-expressed gene pairs or ‘doublets’ across
multiple data sets to infer functional linkages. The
search for doublets was used in the GAN (Gene Aging
Nexus) tool to explore co-expressed gene pairs across
42 data sets related to age [58] and was also recently
implemented in OncoMine [51]. Based on the results
obtained by Lee et al. [22], the Gemma database and
software system was likewise developed for the re-use
and meta-analysis of gene expression.
We have taken into account the advantages of the two
strategies previously described for microarray data ana-
lysis. On those grounds, we developed a tool that makes
muscle transcriptome data meta-analysis easily accessi-
ble to any user. Specifically, we have built a database
that gathers all the public microarray data related to
muscle studies from GEO [13]. After a careful re-analy-
sis of microarray data, clusters of co-expressed genes
were identified in each data set. Converted into lists of
genes, our tool allows the simultaneous comparison of
all clusters independently of the platform used and the
species studied. This comparison enables to identify:
i) robust signatures of a pathology or a treatment
across several independent studies.
ii) sets of genes that may be similarly modulated in
different disease states or following drug treatments.
iii) common sets of co-expressed genes between
human and animal models.
In the remaining sections of this paper, we first pre-
sent the MADMuscle tool. We show how the user can
browse the microarray data related to muscle studies,
examine the annotated clusters and compare his own
gene list with the gene lists relative to all the clusters of
the database. In the next section, we have developed
two meta-analyses to demonstrate the usefulness of our
tool.
Construction and content
We developed the MADMuscle database and an asso-
ciated software tool to improve the comparison of mus-
cle-related expression data from various studies or
organism(s). In addition to just collecting microarray
data, MADMuscle involves an automatic re-normaliza-
tion and re-analysis of all these data sets to identify
clusters of co-expressed genes (see Additional File 1).
These clusters are functionally annotated and displayed
in simple, well-annotated lists of genes, using a universal
identifier. These gene lists, supported by clusters, are
the basis for comparison of microarray data by meta-
analysis (see Additional File 2).
Currently, MADMuscle contains more than 4,400
clusters of co-expressed genes identified from 535 dis-
tinct data sets corresponding to a wide range of condi-
tions, from normal to pathological (for detailed statistics
on the content of the database, see part 1 of the Addi-
tional File 3). Among them, 1,247 clusters automatically
identified as good quality clusters were used for meta-
analysis (developed in section “Utility and Discussion”).
In this section, we first describe how the database was
built, then we present the method used for the extrac-
tion of clusters and finally the database interrogation
(i.e. from a user-defined gene list, the tool provides a list
of statistically similar clusters).
Data Collection and Processing
Data retrieval
Currently, the MADMuscle database collects all tran-
scriptome data sets related to muscle studies from the
public repository Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) [13] of the National
Center for Biotechnology Information (NCBI) at the
National Institutes of Health (NIH). These data sets
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were identified using the following keywords: “muscle”,
“myo”, “heart” or “cardio”. This represents a total of
535 analyzed data sets (see Additional File 1) corre-
sponding to 447 unique GEO series, 116 different
microarray platforms and 7 different species (Homo
sapiens Hs, Mus musculus Mm, Rattus norvegicus Rn,
Canis familiaris Cf, Gallus gallus Gg, Drosophila mela-
nogaster Dm, and Caenorhabditis elegans Ce).
Data re-normalization
Raw data from GEO correspond most of the time to
already pre-processed and/or normalized data. This step
thus aims at normalizing the pre-normalized microarray
data to remove artefacts and to ensure that each entry
of the database follows the same procedure (see details
in part 2 of the Additional File 3 and also Additional
File 4). For each data set the K-nearest neighbors
method [59] was used to evaluate the missing values in
the microarray data sets. Then, non-linear effects such
as background or saturation were corrected by LOWESS
[60], as previously described [61,62], using a channel by
channel procedure [63], each array being individually
normalized to the median profile of all arrays.
Hierarchical clustering
Hierarchical classification [55] was used to investigate
relationships between samples and relationships between
genes both on raw and re-normalized data (Figure 1A, B
and Additional File 1). An average linkage clustering,
using Pearson’s correlation as similarity metric, was
performed with Cluster 3.0 [64] and applied to data
that were log-transformed and median-centred on
genes [65].
Cluster Analysis and Annotation
Cluster selection
Only expression matrixes with at least ten columns/
samples (semi-empirically determined threshold) were
kept for subsequent analysis (see part 3 of the Addi-
tional File 3 for detailed information). Clusters of
co-expressed genes were identified using an iterative
k-means [66] procedure (Figure 1C and Additional
File 1) based on the Forgy’s algorithm [67] and imple-
mented in the statistical software package R [68]. Genes
conserved in 95% of the 1000 independent k-means for
a same cluster were retained (for a more detailed
description of the method, see also part 4 of the Addi-
tional File 3). A total of 4,432 clusters of co-expressed
genes were generated using the stable k-means proce-
dure. An average two-way linkage clustering (i.e. genes
and samples) was also applied to each of these clusters
(Figure 1D and Additional File 1). The resulting heat-
maps (hierarchical clustering and k-means) and trees
were generated with the Linux command line cluster-
gram image creation utility Slcview http://slcview.sour-
ceforge.net.
Outlier detection in clusters
We defined an outlier as an aberrant gene expression
value in one sample. We detected these aberrant values
using a conventional method [69]. Considering a parti-
cular gene and its vector of expression values across
samples, we defined Q1 and Q3 to be the first and third
quartile of this vector. We defined IQR to be the inter-
quartile range (Q3 - Q1), and the interval [Q1 - 1.5 ×
IQR, Q3 + 1.5 × IQR] was defined as the “normal”
range of expression values. We thus considered outliers
as gene expression values that lie outside this range. For
a vector of normally distributed data, this threshold cor-
responds to approximately 5% of the data. For a particu-
lar sample, these aberrant expression values are often
observed for numerous genes. K-means clustering is
sensitive to such repeated aberrant values, leading to a
high number of irrelevant gene signatures. To avoid
such artifacts, we then identified for each gene signa-
ture, samples having gene expression values that are
drastically different from the rest of the samples. In this
context, samples with a proportion of outliers that
exceeds 20% are rejected and the cluster is marked as
“outlier”.
Data set and cluster quality estimation
The quality of a cluster (Figure 1D and Additional
File 1) is determined by a test statistic based on the
Pearson’s product-moment coefficient. Considering a
pair of gene expression profiles, we computed the
p-value from the Student’s t-statistic used to test the
null hypothesis of positive correlation. The quality q of
the cluster c was defined as the geometric mean of the
p-values of all the gene pairs belonging to c. For large
clusters (more than 100 genes), q was estimated using a
resampling technique: the computation was performed
on a subset of 10,000 gene pairs randomly extracted
from the cluster. Note that for clusters marked as “out-
lier”, their quality was estimated from the remainder of
the data set, excluding the samples with a proportion of
outliers >20%. Five quality classes were defined as a
function of the cluster p-value. The quality of a study
(Figure 1A and Additional File 1) was inferred as the
mean quality of its clusters (see part 5 of the Additional
File 3 for more details on the quality classes associated
to the clusters and to the studies).
Functional annotation of clusters
For each microarray platform, gene annotation was
performed with the MADGene tool [70] (see also part
6 of the Additional File 3 for more details on this
database). For each identified cluster of co-expressed
genes, functional annotation (Figure 1D and Additional
File 1) was performed using Gene Ontology (GO) [71]
and GoMiner [72]. Significance of over- or under-
representation of GO terms was calculated using Fish-
er’s exact test.
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Figure 1 Summary of the analysis performed for each data set of the MADMuscle database. The estimated correct (two yellow stars) data
set “GSE1004_GPL91“ from Judith Haslett et al. [8], which explores molecular profiles of dystrophin-deficient (DMD, blue color) and normal (black
color) human muscle, is used as an example. For every analyzed matrix, each row represents a gene, and each column represents a sample.
Each cell in the matrix corresponds to an expression level, with red for over-expression, green for under-expression, and black for gene
expression close to the median (see the color scale). Heat maps resulting from hierarchical clustering (genes and samples) of raw data from GEO
(A) and re-normalized data (B) are given. The heat map of the distinct clusters (from 0 to 8) identified by the stable k-means procedure (C) is
also displayed. After hierarchical clustering (genes and samples), data from each identified cluster (D) are also represented by a heat-map, given
a quality estimation and functionally annotated. Among them, two clusters, which discriminate DMD from normal muscle, are exemplified
(clusters 1 and 5). Cluster 1, estimated as a good cluster (three yellow dots), corresponds to 1,107 genes over-expressed in DMD muscle (DMD+)
and is enriched in genes coding for proteins of the extracellular matrix. On the contrary, cluster 5, estimated as a correct cluster (two yellow
dots), corresponds to 896 genes under-expressed in the DMD muscle (DMD-) and is enriched in genes coding for proteins involved in
translation.
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Database interrogation from a user-defined gene list
The similarity of a cluster with the gene list is based on
a statistical comparison of the genes belonging to the
clusters and the genes given by the user. This function-
ality aims at discovering the studies implying a specific
set of co-expressed genes. The user can thus validate his
gene list with previously published experiments (see
Additional File 2).
Gene list re-annotation
The user can upload his gene list as a tab-delimited text
file. Thanks to the MADGene resource [70] (see also
Additional File 2 and part 6 of the Additional File 3),
the user need not specify the identifier types that are
used in his own list. When a list is submitted, the user
can select the studied species and then the tool displays
the gene annotation that has been performed for
confirmation.
Cluster comparison
MADMuscle statistically assesses the overlap between
the input gene list and the lists relative to all the clus-
ters of the database (see Additional File 2). The concor-
dance between the two lists is calculated as the number
of genes in common divided by the number of genes in
the input list. Although a single gene is allowed to
occur multiple times in the same list, it is counted/con-
sidered only once in the comparisons. When the lists
derive from different species, a gene from the input list
is considered if its homolog is found in the cluster gene
list, as reported in the NCBI HomoloGene database.
MADMuscle performs pair-wise comparisons (Fisher’s
test) and produces a summary table that reports the
number of common genes between the paired lists
along with the p-value. For each comparison, the names
of the common genes can be retrieved.
Main characteristics of MADMuscle tool
MADMuscle gathers a large collection of muscle-related
expression data sets from various studies or organism(s)
(see Additional File 1 and part 1 of the Additional File
3). MADMuscle enables to perform meta-analysis of
these transcriptome data by statistical comparison of
gene lists supported by clusters of co-expressed genes
(see Additional File 2). Indeed gene co-expression is
conserved across many microarray data sets [22]. The
databasing of such microarray gene lists thus allows for
a systematic comparison of the results of various studies
[48] in order to identify consistent expression patterns.
It also helps experimenters to interpret new data in the
context of these biologically significant patterns. For
instance, this approach enabled Parmigiani et al. [73] to
identify genes with consistent expression patterns across
multiple lung cancer-related studies.
The comparison of heterogeneous platforms implies the
conversion of the probe IDs into their corresponding
approved symbols [74]. MADMuscle also takes into
account the information on putative homologs between
species. Once converted, gene lists can thus be compared
whatever the microarray platform used or the species stu-
died. Most of the published tools (e.g. Connectivity Map,
L2L, Oncomine) rely on manual curation of data.
Although these tools are extremely useful, they are labor-
intensive. Thanks to the automatic microarray annotation
tool MADGene [70] (see also Additional File 3, part 6),
MADMuscle analyzes all muscle-related data sets from
GEO in a fully automatic way. This frees users from the
limitations of manually curated data sets, and facilitates
the incorporation of new data.
MADMuscle is freely available and provides a simple
interface for viewing, re-annotating, and compa-
ring gene lists from clusters of co-expressed genes
(for details about data storage and availability, see
also Additional File 3, part 7 and part 8). The meta-
analysis tool (see Additional File 2) highlights strong
overlaps between any two gene lists. The tool compares
each list in the database with the list of genes supplied
by the user, and reports the statistical significance of
any overlap between them. It also re-annotates each
gene on the user’s list with all the lists in the database
on which it is found. The results are presented as a set
of hyperlinked HTML documents, which can be conve-
niently explored by surfing from list to list and from
gene to gene.
Utility and Discussion
This section is divided into two major parts. The first
one is a global analysis of the cluster database indicating
its reliability (Figure 2). The second one is devoted to
the demonstration of the utility and the relevance of the
MADMuscle tool through the presentation of two meta-
analyses related to the DMD (Duchenne Muscular
Dystrophy) (Figure 3 and Figure 4).
Meta-analysis to assess the reliability of the cluster
database
Pairwise comparisons of the clusters
The objective was to identify common transcriptional
programs of muscle development across a wide range of
microarray data sets. Therefore, we systematically com-
pared each cluster of the database to all others, using
the statistical test presented in the section “Cluster com-
parison“. Instead of one input gene list, we successively
introduced all the gene lists contained in the cluster
database. This pairwise comparison of clusters is illu-
strated in Figure 2. Each of the 1,247 “good” labeled
clusters of the database was systematically compared to
all others using the Fischer exact test to detect signifi-
cant similarity (strong overlap) or dissimilarity (poor or
no overlap). The resulting p-values were computed to
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generate the diagonally symmetric similarity matrix for
the 1,247 clusters (Figure 2A).
Compiling large numbers of microarray studies in a
single database simplifies the analysis as it integrates
many conventional assays into a single genome-wide
expression profile. Thus the results from different
studies can be compared directly [23]. However, micro-
array studies often generate gene signatures consisting
of hundreds of genes, making it difficult to distinguish
which gene expression features are critical. For instance,
in some data sets, a gene may show little variation and
may have no co- expressed genes, whereas in other data
Figure 2 Hidden patterns revealed by meta-clusters across muscle-related transcriptome data sets. A- The right-hand side presents a
systematic meta-analysis of all the “good” clusters from the MADMuscle database. The results are represented by the diagonally symmetric
interaction matrix for 1,247 clusters of co-expressed genes based on statistical comparison (p-values). Red indicates significant similarity (strong
overlap), green significant dissimilarity (poor overlap) and grey no overlap between compared clusters. The matrix was ordered using hierarchical
clustering (lines and columns) to highlight groups of similar clusters. The resulting visualization uncovers 6 main components of highly similar
and interconnected clusters, called meta-clusters (M1 to M6), involved in similar biological processes. B- On the left-hand side, a three-
dimensional representation of the functional annotation of the meta-clusters is given. The functional annotation is visualized as a terrain map, in
which highly correlated Gene Ontology (GO) terms are placed in proximity in the x-y plane and the probability density of enrichment in a
region is shown by the altitude in the z direction. Each line represents a different GO term with cold colors for enrichment values <1 and hot
colors for values >1 (see color scale). The rows (7554 GO terms) were ordered by hierarchical clustering, placing terms with similar annotation
patterns together. The columns (clusters) were ordered in the same order as in the clustered diagonally symmetric interaction matrix (right-hand
side of the figure). Specific significant GO annotation is associated to each Meta-cluster. For instance, the meta-cluster M4 supports genes
encoding muscle and mitochondrion proteins.
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sets the same gene may be part of a robust cluster of
co-expressed genes [22]. In this type of situation, it is
useful to compare the results of different studies - by
means of meta-analysis - to determine which results are
most robust and most consistent across a range of
studies.
Identification of core meta-clusters
The result of our analysis is a global map showing the
clusters that are shared under a wide variety of physiolo-
gical conditions (Figure 2A). The classification of this
map identified 6 major, distinct and wide meta-clusters
(M1 to M6). Each of them contained at least 15 similar
Figure 3 Using the MADMuscle meta-analysis tool to perform systematic cross-species and cross-platform comparisons independently
from the studied samples. A- For each of the two input gene lists (clusters 1 and 5 presented in Figure 1), the 50 top overlapping clusters
from the database were identified. Red and green backgrounds indicate significant overlaps with cluster 1 (DMD+) and cluster 5 (DMD-)
respectively. Non-significant overlaps are displayed by a brown background. The 100 best-hit clusters, showing significant similarity with either
cluster 1 or 5, cover 5 distinct species and 18 distinct microarray platforms (see color legend). B- Among the 100 top similar clusters, 3 particular
results of overlapping genes are illustrated for cluster 1 (I, II and III) and 3 others for cluster 5 (IV, V, VI). For instance, 283 genes had increased
expression (similarity p-value p = 1.57e-66) in both DMD muscle (input cluster 1) and mdx muscle (output cluster II). On the contrary, expression
of 119 genes was commonly decreased (p = 6.96e-21) in both DMD (input cluster 5) and mdx (output cluster VI) muscles. C- Functional
annotation of clusters 1 and 5 was inferred from their 50 best hits. For each of the 100 top clusters, the five top gene ontology (GO) terms are
displayed using the same color code as depicted in part A. Cluster 1 resembles clusters enriched in genes coding for proteins of the
extracellular matrix and proteins involved in immune response. Cluster 5 has similarity with clusters preferentially containing genes coding for
muscle and mitochondrion proteins.
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Figure 4 Using the MADMuscle meta-analysis tool to refine gene expression patterns in a given pathology with a high level of
confirmation. A- Heat map showing the differentially expressed genes in DMD muscle from our data set. B- Heat map (merged overlapping
clusters) of gene expression in normal and DMD muscle from five independent studies of the database. Samples (columns) were classified
according to the experimental group (DMD and normal) and the data set of origin (see color legend). For each gene (rows), the yellow and
purple bars indicate the total number of measurements (0 to 5) across studies and the computed p-values from the student’s t-test. C- The
comparison (A and B) identified 8 different classes of gene expression depending of their status in our data set ("+": over-expression; “-": under-
expression) and across the other studies ("+/-": over/under-expression; “NS": no significant differential expression; “NP": no present in the clusters).
Among them, the two classes +/+ and -/-, corresponding to genes commonly up- or down-regulated across all the DMD studies, are illustrated
by some particular gene names (right hand side). D- Multidimensional scaling (MDS) [83] analysis of gene proximity (genes +/+ and -/-) given by
the 1,247 “good” labeled clusters of the database. Results of the projection are represented by a 2 D plot in which green and red indicate gene
commonly under and over-expressed in DMD muscle (classes -/- and +/+). Symbols (circle, square or triangle) illustrate particular Gene Ontology
(GO) terms associated to these genes (see legend).
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clusters from various studies, microarray platforms or
species. Many other small meta-clusters, gathering less
than 10 clusters, could also be identified but will not be
discussed in the present study. Whereas M1 gathered 16
clusters, 79 clusters were found in M2, 25 in M3, 46 in
M4, 59 in M5 and 19 in M6.
Functional annotation of core meta-clusters
It is likely that conserved co-expression patterns
between studies have a functional relationship [22]. A
sufficiently large and diverse set of profiles, obtained
from various conditions, results in a relatively compre-
hensive identification of co-expressed transcript groups.
This allows additional hypotheses to be drawn regarding
the functions of genes based on the regulatory charac-
teristics of their transcripts. Such an approach better
reflects specific biological processes [55-57]. To assess
the reliability of these meta-clusters, we evaluated their
functional annotation by examining the overlap of
GO terms for each cluster of co-expressed genes
(Figure 2B). By taking into account both enrichment
and p-values, we clearly showed that each of the identi-
fied meta-clusters is associated with specific GO terms.
The functional annotation of the meta-clusters is
discussed in part 9 of the Additional File 3.
This study enabled us to identify a transcriptional
landscape of skeletal muscle. It correctly infers a num-
ber of known fundamental biological processes within a
skeletal muscle context. We found that a substantial
number of correlated expression patterns occur in mul-
tiple independent data sets (Meta-clusters). Since tight
correlation may imply common regulation [75] the iden-
tification of the precise role of transcription factors (e.g.
ESRRA) in the coordination of gene expression patterns
will be followed by studies on muscle pathology as was
recently done for other tissues [76].
Meta-analysis to investigate the genomics of DMD muscle
In this part, we aim to demonstrate the utility and the
relevance of the MADMuscle tool. With this objective
in mind, we developed two analyses (Figure 3 and
Figure 4) showing how easy and quick meta-analysis can
produce novel biological insights from the large com-
pendium of microarray data.
The first analysis illustrates the fact that conserved
gene expression patterns can be identified between dif-
ferent pathologies and animal models. In this case, gene
expression changes in different models are sufficiently
similar to suggest a common underlying mechanism.
To this end, two particular clusters (cluster 1 and 5,
detailed in Figure 1) - discriminating normal from
Duchenne Muscular Dystrophy (DMD) muscle in
Haslett’s data set [8]- were used as input gene lists and
compared to the rest of the database (Figure 3 and
part 10 of the Additional File 3).
The second analysis shows how robust biomarkers can
be identified for a given pathology (see part 11 of the
Additional File 3). Similar patterns of gene expression
changes are easily found in several data sets to clearly
define a set of pathology-related genes. Focusing on the
DMD pathology, we first used the results from our own
data set as input external gene lists (see part 12 of the
Additional File 3). Then we retrieved the related studies
from the database thanks to our query tool. Finally, we
integrated them to identify robust biomarkers (Figure 4).
Comparison of DMD with other diseases
Selection of two input gene lists
To illustrate the capacity of MADMuscle to perform
such comparisons, we chose two clusters (Figure 1C and
1D) from the re-analyzed “GSE1004_GPL91” data set
[8], which discriminate normal muscle from muscle
affected by Duchenne Muscular Dystrophy (DMD).
DMD is a severe genetic myopathy caused by the lack
of the sarcolemmal protein dystrophin, and is clinically
characterized by progressive and irreversible degenera-
tion of muscle tissue. The first cluster (cluster 1,
DMD+) contains 1,107 genes over-expressed in DMD
muscle and involved in extracellular cell-matrix
adhesion and the inflammatory-immune response
(Figure 1D). The second cluster (cluster 5, DMD-) cor-
responds to 896 genes under-expressed in DMD muscle
and involved in translation or coding for mitochondrion
proteins (Figure 1D). Our results confirm the authors’
initial observations [8] that many of the differentially
expressed genes reflect changes in infiltration by inflam-
matory cells and connective tissue. Taken together,
these two clusters recapitulate the major pathological
feature of DMD which is abnormal connective tissue
proliferation following myofiber degeneration.
Systematic meta-analysis of gene expression data
These histological observations, although dramatically
exacerbated in the DMD muscle, should also be present
in other pathological or physiological conditions. For
instance, skeletal muscle fibrosis, along with connective
tissue proliferation, is a major pathological hallmark of
chronic myopathies. In these pathologies, myofibers are
replaced by progressive deposition of collagen and other
extracellular matrix proteins produced by muscle fibro-
blasts. It is thus reasonable to argue that the coordi-
nated gene expression patterns that reflect these
histological changes will be conserved across studies.
Comparing genomic expression profiles across species
can reveal evolutionary conserved mechanisms, as illu-
strated in McCarrol et al. [36]. Based on the MADMus-
cle meta-analysis tool, the 50 best hits for each of the
two input gene lists (cluster 1 and cluster 5) were iden-
tified and analyzed (see Figure 3). These 100 clusters
differ largely in their gene composition: 50 clusters
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display significant resemblance with the DMD+ cluster
1, while the 50 others contain significantly more genes
observed in the DMD- cluster 5 (Figure 3A). Among the
100 top clusters showing significant overlaps with either
cluster 1 or cluster 5, we identified 5 distinct species
(Homo sapiens Hs, Mus musculus Mm, Rattus Norvegi-
cus Rn, Canis familiaris Cf and Gallus gallus Gg), 18
distinct microarray platforms and various physiological
conditions (including other muscle pathologies). This
result underlines the capacity of the tool to highlight
co-expressed genes across studies. We chose some typi-
cal examples among the 100 output results to illustrate
this feature (Figure 3B). We found for instance that the
two DMD gene signatures, namely DMD+ (cluster1)
and DMD- (cluster 5), strongly resemble their counter-
parts (respectively II and VI: GSE466_GPL81) in the 16-
wk-old mouse mdx muscle - the animal model of DMD
- in spite of real discrepancies pointed out in the study
[77]. Additional information can be found in part 10 of
the Additional File 3.
Functional re-annotation
Finally, MADMuscle allows the identification of genes
that change repeatedly in different studies, even when
the studies are on different species or microarray plat-
forms. The deregulation of these genes is caused by
similar histological changes in the studied tissues. Rein-
forcing this idea is the fact that the GO terms (Figure
3C), supported by each of the 100 resulting clusters, fit
very well with the direct functional annotation deduced
from the two signatures DMD+ and DMD-. The GO
terms associated with the 50 clusters resembling the
DMD+ signature converged towards the extracellular
matrix and the immune response; those associated with
the 50 clusters resembling the DMD- signature identi-
fied muscle and mitochondrion markers. It is remark-
able that functional annotation of the two signatures
could thus have been deduced a posteriori from the
meta-analysis. This may simplify the interpretation of
lists of genes with altered expression, a critical and
time-consuming part of microarray research.
Comparison of DMD microarray studies
Meta-analysis to identify similar gene clusters
We used our own transcriptional analysis of muscle
(fascia lata tensor or paravertebral) affected by DMD.
This study is presented in part 12 of the Additional
File 3. We obtained two lists of differential genes
(Figure 4A): 483 genes were over-expressed (gene list
“+”) in the DMD muscle, 473 genes showed a clear
down-regulation (gene list “-”). The two gene lists (+: up
and -: down) from our study (Figure 4A) were com-
puted using MADMuscle. Because of the conserved co-
expression across studies [22], these two gene lists
enabled us to retain clusters of co-expressed genes from
5 distinct independent GEO series related to DMD stu-
dies (Figure 4B) (GSE465 [78], GSE1004 [8], GSE1007
[79], GSE3307 [80], and GSE6011 [81]),
Integration of output data
The resulting clusters from each study were merged to
create a meta-matrix (Figure 4B) in which genes differ-
entially expressed between DMD and normal muscles
were identified. The p-values can be calculated in each
individual study and then combined, yielding an overall
estimate of gene significance [23]. Another approach is
to apply p-value combination only after the construction
of a meta-profile, defined as the trimmed median
expression profile of all the equally annotated features
[82]. The combination of results from different studies
partially solves the problem of a small sample number
(inherent to microarray experiments) and thus helps to
detect the truly differentially expressed genes. We there-
fore applied a Student’s t-Test (p-value <0.01) on each
gene expression meta-profile to identify significant varia-
tions between the control meta-group and the DMD
meta-group. Reliably deregulated genes (meta-clusters of
either up-regulated or down-regulated in DMD muscle)
as well as invariant genes were identified.
Data validation
The results from the meta-matrix were confronted to
those from our study (Figure 4C). As expected from the
small number of samples explored in our data set, part
of the results could not be validated (false positives).
Actually, some DEGs were not present (NP) in MAD-
Muscle clusters, indicating that they did not significantly
vary in any data set (+/NP: 87 genes; -/NP: 113 genes).
Other DEGs were not significant in most MADMuscle
clusters (+/NS: 155 genes; -/NS: 179 genes). Some DEGs
even varied significantly in the opposite sense to that
observed in our study (+/-: 39 genes; -/+: 72 genes).
These discrepancies in the results could reflect a mus-
cle-type effect since in our study we used paravertebral
and fascia lata tensor muscles whereas in the public
data sets, mainly quadriceps muscle biopsies were inves-
tigated. On the contrary, 202 DEGs were found to be
significantly up-regulated both in MADMuscle clusters
and in our study (+/+ group) while 109 DEGs showed a
clear down-regulation (-/- group).
Finally, to assess the differences between these two
complete gene lists (+/+ and -/-), we analyzed their
expression patterns, given by the 1,247 “good” labeled
clusters of the database, with a Multidimensional scal-
ing (MDS) [83]. This approach is particularly pertinent
for the visualization of the similarities and differences
observed in the data (Figure 4D and part 13 of the
Additional File 3). The results, represented as a 2 D
plot, show a clear separation between DMD+ (red) and
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DMD- (green) genes, achieved along one of the two
components of the plot. One can note that DMD+
genes spread more widely than DMD- genes. This is
probably due to the fact that in the DMD muscle,
most of the up-regulated genes correspond to different
invading cell types. Interestingly, genes from these two
groups are also preferentially associated with specific
GO terms (e.g. “mitochondrion” for DMD- genes;
“extracellular region” and “cell adhesion” for DMD+
genes).
These observations are in agreement with the conclu-
sions from previous studies on DMD muscle. In addi-
tion, among the perturbed biological functions, new
interesting functions were identified by this meta-analy-
sis and will be the scope of further studies. For instance,
among the DMD+ genes, we clearly found an over-
representation of GO terms associated with muscle
(GO:0007517) and neuron (GO:0022008; GO:0048699)
development. This could be explained by the following
situation: while the satellite cell pool is quickly
exhausted by repeated cycles of degeneration and regen-
eration [84], other resident muscle cell populations [85]
may also contribute to muscle fiber regeneration, along
with reinnervation [86,87] in the dystrophic muscle.
These findings are now under investigation to clarify the
precise role of these biomarkers in the context of the
pathology.
Conclusion
We have defined a new microarray meta-analysis tool
named MADMuscle. Our methodology allows biologists
to easily explore a large collection of microarray data
related to muscle, through a user-friendly web interface
with browse and search functions at multiple levels.
While useful for microarray data comparison, MAD-
Muscle is not limited to microarray results, and is
equally capable of comparing results from other high-
throughput technologies (SAGE, ChIP-on-chip or ChIP-
seq, Protein-array and other proteomic analyses, large
scale Real-time PCR, etc.). The only limitation is that
the input data must correspond to a gene list. Finally,
this work provides a simple and scalable framework for
comparing and assessing the intersection of multiple
gene expression signatures from disparate data sets.
This approach will be increasingly useful as the mass of
published transcriptome data grows. We are continually
maintaining, improving and adding new functionalities
to our tool. The database content will be updated once
a year. We notably plan to include muscle transcriptome
data sets from the ArrayExpress repository (EBI) in the
next version of MADMuscle database. Moreover, the
database and methods we describe here can form
the basis for further large-scale explorations of gene
expression data.
Availability and requirements
The MADMuscle tool is freely available online from
http://www.madtools.org, a web site dedicated to the
analysis and annotation of DNA microarray data.
Additional material
Additional File 1: The MADMuscle web interface - database. In this
supplementary file, we present the database web interface with different
screenshots.
Additional File 2: The MADMuscle web interface - meta-analysis
tool. In this supplementary file, we present the meta-analysis tool web
interface with different screenshots.
Additional File 3: Supplementary material and results. In this
supplementary file, we give additional information and comments about
the procedures and the results.
Additional File 4: Re- normalization of MADMuscle data sets. In this
supplementary file, we illustrate the re-normalization procedure of each
data set to correct remaining bias.
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